C8-Alcyne-dU-CEP, ≥95%, 5 g, emballage plastique.

5-Amino-2-(trifluoromethyl)pyridine>98.0%(GC)(T)5g

Methyl 3-iodoimidazo[1,2-a]pyridine-7-carboxylate, 95.0%, 5g

(4R)-4-Methylpyrrolidin-2-one, 97%, 250mg

Di-tert-butyl piperazine-1,4-dicarboxylate, 95.0%, 250mg

(S)-4-(4-(4-(((2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, 98.0%, 5mg

H-D-Ala-OiPr.HCl, 95.0%, 100g

Ethyl 5-(4-bromophenyl)-[1,2,4]oxadiazole-3-carboxylate, 95.0%, 5g

(S)-4-PHENYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

(S)-N-[3-(3-Fluoro-4-iodophenyl)-2-oxo-oxazolidin-5-ylmethyl]acetamide, 95.0%, 100mg

(2R,3S)-N-Boc-3-phenylisoserine methyl ester, 95.0%, 5g

Ethyl 2-(thiophen-2-yl)thiazole-4-carboxylate, 95.0%, 10g

1-Benzyl-1H-pyrazole-4-carboxaldehyde>98.0%(GC)1g